Cite
HARVARD Citation
Martínez-López, J. et al. (2021). The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study. Leukemia & lymphoma. 62 (8), pp. 2040-2043. [Online].